op 2507 has been researched along with alprostadil in 2 studies
Studies (op 2507) | Trials (op 2507) | Recent Studies (post-2010) (op 2507) | Studies (alprostadil) | Trials (alprostadil) | Recent Studies (post-2010) (alprostadil) |
---|---|---|---|---|---|
33 | 0 | 1 | 7,136 | 864 | 761 |
Protein | Taxonomy | op 2507 (IC50) | alprostadil (IC50) |
---|---|---|---|
Multidrug resistance-associated protein 4 | Homo sapiens (human) | 2.3 | |
Solute carrier organic anion transporter family member 2B1 | Rattus norvegicus (Norway rat) | 0.0358 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoyama, T; Fukuse, S; Nagahara, K; Noi, O | 1 |
Umeki, S | 1 |
2 other study(ies) available for op 2507 and alprostadil
Article | Year |
---|---|
Effects of prostaglandins on perilymphatic oxygenation. Enhancement of cochlear autoregulation by prostacyclin.
Topics: Alprostadil; Animals; Blood Flow Velocity; Blood Pressure; Cats; Cochlea; Epoprostenol; Homeostasis; Labyrinthine Fluids; Methacrylates; Microcirculation; Oxygen Consumption; Perilymph; Regional Blood Flow; Ultrasonography | 1988 |
Prostaglandin E and analogs of prostacyclin influencing superoxide production by the human neutrophil NADPH oxidase system.
Topics: Alprostadil; Dose-Response Relationship, Drug; Epoprostenol; Free Radical Scavengers; Humans; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Prostaglandins, Synthetic; Superoxides | 1994 |